Death Star Hemp Derived Terps – HHC 99% Hexahydrocannabinol Vape Carts

Sale!

Death Star Hemp Derived Terps – HHC 99% Hexahydrocannabinol Vape Carts

$39.99

In stock

Death Star Hemp Derived Terps – HHC 99% Hexahydrocannabinol Vape Carts

Death Star, also known as “Deathstar,” is a popular indica marijuana strain bred from a potent cross of Sensi Star and Sour Diesel. Death Star offers skunky sweet jet fuel aromas that are pungent and fill up your nostrils. This strain may not have the ability to destroy planets, but it does have quit a powerful buzz

What is HHC (Hexahydrocannabinol)?

HHC is a cannabinoid that is naturally found in the seeds and pollen of hemp. HHC is not a THC, so while it may have similar effects – it is non-synthetic. Which makes it a perfectly federally legal hemp extraction.

What are the Effects of Hexahydrocannabinol?

HHC effects are very very similar to THC, but HHC does have differences. Some people claim it gives them the same euphoric feeling, pain-fighting, and anti nausea/vomiting effects that THC does. Some just enjoy the Buzz 🙂

What makes hexahydrocannabinol different than THC?

Want to get technical? Let’s get technical.

HHC has shown to have an extremely high binding affinity for CB1 and CB2 Cannabinoid receptors in your body, and it is a potent cannabinoid in vitro and in vivo.

HHC has three chiral centers, meaning it has three different forms of it. These forms are called enantiomers, and they are essentially mirror images of each other. The three enantiomers of HHC have different effects on the body, depending on which chiral center they bind to.

  • The first chiral center is C1. If HHC binds to this chiral center, it will activate the CB1 receptor.
  • The second chiral center is C2. If HHC binds to this chiral center, it will activate the CB2 receptor.
  • The third chiral center is C3. If HHC binds to this chiral center, it will not activate either the CB1 or CB2 receptor.

The differences between the three enantiomers of HHC are important because they show that HHC can bind to two different receptors (CB1 and CB2), but it can only activate one of them (CB1). This means that HHC can potentially treat two conditions at once: a condition related to the immune system and a condition related to the CNS and cardiometabolic disorders.